Carl Zeiss Meditec AG (AFX.DE) Stock

Healthcare · Medical Instruments & Supplies · Member of SDAX, TecDAX

Carl Zeiss Meditec AG (AFX.DE) closed at EUR 33.02 on 2026-10-14, a change of -24.1 % over the past year, with a market capitalization of EUR 2.87B.

Carl Zeiss Meditec AG recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Carl Zeiss Meditec AG key figures

Previous close

EUR 33.02 (2026-10-14)

1-year change

-24.1 %

Market cap

EUR 2.87B

Enterprise value

EUR 3.39B

P/E ratio (trailing)

23.06

P/E ratio (forward)

22.45

EPS (trailing)

1.42

EPS (forward)

1.46

PEG ratio

1.14

Price to book

1.37

Revenue growth

2.4 %

Earnings growth

97.5 %

Dividend per share (trailing)

0.55

Short ratio

n/a

Employees

5,784

Analyst consensus (third-party)

underperform

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for retina examination; functional glaucoma diagnostic devices (perimeters); surgical ophthalmology products comprising surgical microscopes, biometers, and phacoemulsification and vitrectomy equipment; intraocular lenses for cataract surgery; and systems and consumables for laser eye surgery that include the VISUMAX femtosecond laser, which enables minimally invasive correction of vision defects using lenticular extraction, as well as digital products for the storage, analysis, and sharing of clinical data. The Microsurgery segment provides products and solutions for minimally invasive surgical treatments, including surgical visualization, interoperative radiotherapy, interoperative pathology, special surgical instruments, and digital solutions, as well as the ZEISS Tumor Workflow, a cross-product workflow solution. It serves physicians in various fields and hospitals. The company has a strategic collaboration with Envision Health Technologies Inc. to help advance glaucoma care through gamified virtual reality technology. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG operates as a subsidiary of ZEISS Group.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Carl Zeiss Meditec AG and compare it with other stocks.